Trials / Active Not Recruiting
Active Not RecruitingNCT06599229
Perfusion Abnormalities in Hypertrophic Cardiomyopathy
Myocardial Perfusion Abnormalities in Hypertrophic Cardiomyopathy
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (estimated)
- Sponsor
- University of Virginia · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate whether myocardial microvascular perfusion in patients with hypertrophic cardiomyopathy improved after initiation of cardiac myosin inhibitor therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | myocardial contrast echo | Vasodilator stress myocardial contrast echocardiography will be performed at baseline and within 4 months of reaching target dose of a cardiac myosin inhibitor. |
Timeline
- Start date
- 2025-01-02
- Primary completion
- 2026-05-30
- Completion
- 2026-12-01
- First posted
- 2024-09-19
- Last updated
- 2026-04-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06599229. Inclusion in this directory is not an endorsement.